Organ and Tissue Transplantation: A Global Strategic Business Report
San Jose, California (PRWEB) September 19, 2014
Follow us on LinkedIn – Buoyed by technological advancements, surgical techniques, and immunosuppressant drugs to prevent rejection, organ transplantation has become the preferred treatment for several chronic diseases related to the heart, kidneys, lungs, pancreas, and liver. Advancements in organ and tissue transplantation have phenomenally revolutionized the survival rate of terminal ill patients. Organ transplant today represents a pivotal medical intervention for thousands of patients suffering from end-stage diseases. While tissue transfer enhances the quality of life of a patient, organ transfer saves the lives of patients suffering from organ failures. The organ transplant industry, however, is hugely reliant on voluntary philanthropy and altruism in organ donation thus keeping supply of organs always under pressure. Although donations of cadaveric organs have decreased, living donor organs have witnessed a relative increase in recent times. Rising awareness and dissemination of information promoting organ and tissue donation have been playing a major role in increasing living organ donation. Turkey recorded the highest number of living organ donors in 2013, at around 46.6 per million population (PMP).
Major challenges to growth in the market include limited supply of organs, and huge expenses associated with transplant surgeries. Dearth of organs has been adversely affecting the number of transplant procedures, as several chronically ill patients waiting for organ transplants die without the receipt of a suitable organ. This, in turn, is encouraging the black market for organs, as well as propelling the medical tourism market, which is driving people overseas to buy organs for transplantation. Though Donation after Circulatory Death (DCD) is an ethically controversial issue, DCD patients represent a huge untapped reserve of potential organ donors. Consent to donate and formulating proper means to procure organs from this untapped pool can effectively address the organ shortage issue.
As stated by the new market research report on Organ and Tissue Transplantation, Europe represents the largest market worldwide supported by widespread awareness and willingness of donate organs. Norway and Belgium recorded the highest number of transplants PMP in 2012. Asia-Pacific and Latin America are forecast to witness promising growth with China and other Asian countries emerging as medical tourism destinations for organ transplantation services. Asia-Pacific is slated to grow at a compounded annual rate of 6.8% over the analysis period. Europe dominates the global kidney and liver transplant market, while the United States holds the largest share in heart, lung, pancreas, and corneal transplants.
Key players covered in the report include CryoLife Inc., Exactech Inc., Folio Biosciences, Köhler Chemie, LifeCell Corporation, Medtronic Inc., Organogenesis Inc., Organ Recovery Systems, Organ Transport Systems, and XVIVO Perfusion AB, among others.
The research report titled “Organ and Tissue Transplantation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, challenges, mergers, acquisitions, other strategic corporate activities of major companies worldwide. The report provides market estimates and projections of number of procedures for all major geographic markets, including the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Key organ transplantation types analysed in the report include Heart, Kidney, Liver, Pancreas, Lung, and Intestine. Additional segments covered for the US market include Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), Graft Type (Autologous grafts, Allografts, Other Material), and Bone Graft Application (General Orthopedics, Spinal Fusions, and Craniao/Maxillofacial).
For more details about this comprehensive market research report, please visit – http://www.strategyr.com/Organ_and_Tissue_Transplantation_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
###
